Stratos Wealth Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $236K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $281K | Sell |
|
|||||
|
2024
Q3 | $362K | Sell |
|
|||||
|
2024
Q2 | $451K | Buy |
|
|||||
|
2024
Q1 | $528K | Sell |
|
|||||
|
2023
Q4 | $574K | Sell |
|
|||||
|
2023
Q3 | $491K | Buy |
|
|||||
|
2023
Q2 | $423K | Buy |
|
|||||
|
2023
Q1 | $381K | Sell |
|
|||||
|
2022
Q4 | $464K | Sell |
|
|||||
|
2022
Q3 | $431K | Sell |
|
|||||
|
2022
Q2 | $501K | Sell |
|
|||||
|
2022
Q1 | $710K | Buy |
|
|||||
|
2021
Q4 | $876K | Sell |
|
|||||
|
2021
Q3 | $1.03M | Buy |
|
|||||
|
2021
Q2 | $795K | Hold |
|
|||||
|
2021
Q1 | $623K | Buy |
|
|||||
|
2020
Q4 | $510K | Sell |
|
|||||
|
2020
Q3 | $472K | Sell |
|
|||||
|
2020
Q2 | $370K | Buy |
|
|||||
|
2020
Q1 | $257K | Hold |
|
|||||
|
2019
Q4 | $312K | Buy |
|
|||||
|
2019
Q3 | $263K | Hold |
|
|||||
|
2019
Q2 | $282K | Hold |
|
|||||
|
2019
Q1 | $289K | Hold |
|
|||||
|
2018
Q4 | $225K | Hold |
|
|||||
|
2018
Q3 | $268K | Buy |
|
|||||
|
2018
Q2 | $202K | Hold |
|
|||||
|
2018
Q1 | $192K | Sell |
|
|||||
|
2017
Q4 | $198K | Buy |
|